Cambridge University PressEdition: Reissue, 5/27/2011EAN 9780521116947, ISBN10: 0521116945Paperback, 458 pages, 24.4 x 17 x 2.4 cmLanguage: EnglishScreening is regarded as a cost-effective and clinically useful approach for the early diagnosis of several malignancies, especially such common cancers as those of the breast and the cervix. This 1991 is a publication from the Project on evaluation of Screening for Cancer, organized by the International Union Against Cancer (UICC), one of the world's foremost agencies in the field of cancer epidemiology and control. It contains recommendations from the international authorities on cancers for which screening is used. Findings from studies in many countries are presented and evaluated, and methodological issues are also discussed. This is an influential and authoritative statement on the scope of cancer screening. It will be of interest to oncologists, epidemiologists and others in the public health field.PrefacePart I. Screening for Breast CancerState of the Art on Breast Cancer Screening1. Sensitivity and specificity of screening in the UK trial of early detection of breast cancer2. Screening for breast cancer in Finland3. The Swedish two-county trial of mammographic screening for breast cancerrecent results on mortality and tumour characteristics4. The Malmö mammographic screening trial5. The Canadian national breast screening study6. The USSR/Germany/WHO BSE study and global strategies for the control of breast cancer7. A cost-effectiveness approach to breast cancer screening8. Summary of the discussion on breast cancer screeningPart II. Screening for Colorectal CancerState of the Art on Screening for Colorectal Cancer9. Colon cancer control studystatus and current issues10. An update on the Nottingham trial of faecal occult blood screening and rescreening of 51 325 subject12. Interim report on a randomised trial of screening for colorectal cancer with Hemoccult-II13. Case-control evaluation of colorectal cancer screening in the Federal Republic of Germany14. Summary of the discussion on colorectal cancer screeningPart III. Screening of Cancer for the CervixState of the Art on Screening for Cancer of the Cervix15. The natural history of cancer of the cervix, and the implications for screening policy16. Effect of organized screening on the risk of cervical cancer in the Nordic countries17. The organisation of cervical screening in England and Wales18. Indications for colposcopy from a UK viewpoint19. Screening for cervix cancer in developing countries20. Summary of the discussion on screening for cancer of the cervixPart IV. Screening for Ovarian CancerState of the Art on Screening for Ovarian Cancer21. Tumour markers in screening for ovarian cancer22. Phase I investigation for early diagnosis of ovarian carcinomawhat problems are to be expected in a larger screening programme?23. Screening for ovarian cancer24. Summary of the discussion on screening for ovarian cancerPart V. Screening for Malignant MelanomaState of the Art on Screening for Melanoma25. Screening and early diagnosis for melanoma in Australia and New Zealand26. Screening for melanoma in the UK27. Screening for melanoma/skin cancer in the United States28. The dysplastic naevus syndromeimplications for screening29. Summary of the discussion on screening for melanoma of the skinPart VI. Screening for Prostate CancerState of the Art on Screening for Prostate Cancer30. Issue in screening for prostate cancer31. Available screening tests for prostate cancer32. Evaluation of screening for prostate, lung and colorectal cancers :the PLC trial33. Summary of the discussion on screening for cancer of the prostatePart VII. Screening for NeuroblastomaState of the Art on Screening for Neuroblastoma34. Neuroblastomastudies in Japan35. Screening for neuroblastoma, background, preliminary experience in the North of England and proposals for an evaluative study36. Summary of the discussion on screening for neuroblastomaPart VIII. Screening for Stomach CancerState of the Art on Screening for Stomach Cancer37. Evaluation of mass screening programme for stomach cancer in Japan38. Summary for the discussion of screening for stomach cancerPart IX. Screening for Nasopharyngeal CancerState of the Art on Screening for Nasopharyngeal Cancer39. Screening for nasopharyngeal carcinoma40. Summary of the discussion on screening for nasopharyngeal cancerPart X. Methodological Issues41. Surrogate measures in the design of breast screening trials42. Recent developments in cancer screening modeling43. Case-control studies of screening44. Summary of the discussion on new approaches to the evaluation of screening.
